Captopril-d3

CAT:
804-HY-B0368S
Size:
100 µg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Captopril-d3 - image 1

Captopril-d3

  • Description :

    Captopril-d3 is deuterium labeled Captopril. Captopril (SQ 14225), antihypertensive agent, is a thiol-containing competitive, orally active angiotensin-converting enzyme (ACE) inhibitor (IC50=0.025 μM) and has been widely used for research of hypertension and congestive heart failure. Captopril is also a New Delhi metallo-β-lactamase-1 (NDM-1) inhibitor with an IC50 of 7.9 μM[1][2][3].
  • Product Name Alternative :

    SQ 14225-d3
  • UNSPSC :

    12352005
  • Hazard Statement :

    H317-H361
  • Target :

    Angiotensin-converting Enzyme (ACE) ; Isotope-Labeled Compounds
  • Type :

    Isotope-Labeled Compounds
  • Related Pathways :

    Metabolic Enzyme/Protease; Others
  • Applications :

    Neuroscience-Neuromodulation
  • Field of Research :

    Cardiovascular Disease
  • Solubility :

    10 mM in DMSO
  • Smiles :

    OC([C@@]1(CCC([2H])(N1C([C@@H](CS)C)=O)[2H])[2H])=O
  • Molecular Formula :

    C9H12D3NO3S
  • Molecular Weight :

    220.30
  • Precautions :

    P261-P272-P280-P302+P352-P362+P364-P405-P501
  • References & Citations :

    [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Afrin S, et al. Eritadenine from Edible Mushrooms Inhibits Activity of Angiotensin Converting Enzyme in Vitro. J Agric Food Chem. 2016;64 (11) :2263-2268.|[3]Esmaeili S, et al. Captopril/enalapril inhibit promiscuous esterase activity of carbonic anhydrase at micromolar concentrations: An in vitro study. Chem Biol Interact. 2017;265:24-35.|[4]Li N, et al. Simplified captopril analogues as NDM-1 inhibitors. Bioorg Med Chem Lett. 2014;24 (1) :386-389.|[5]Song, J.C. and C.M. White, Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update. Clin Pharmacokinet, 2002. 41 (3) : p. 207-24.|[6]Tzakos, A.G., et al., The molecular basis for the selection of captopril cis and trans conformations by angiotensin I converting enzyme. Bioorg Med Chem Lett, 2006. 16 (19) : p. 5084-7.
  • Shipping Conditions :

    Room temperature
  • Scientific Category :

    Isotope-Labeled Compounds
  • Clinical Information :

    No Development Reported
  • CAS Number :

    [1356383-38-4]

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide